Synthetic biology research is conducted at small scale in laboratory conditions. These conditions may not be ideal for subsequent scale-up for commercialisation. Chassis selection, media feed stocks and down-stream processes suitable for the laboratory may not be suitable in a production setting. As such, considerations of scale-up must be built in to early stage research to avoid problems, which may impede translation or affect profitability.

Objectives

This workshop aims to address the knowledge gap between many synthetic biology researchers and the bioprocessing communities. The specific objectives are to:

• Identify common challenges for scale up of synthetic biology products and how these challenges have been addressed in other similar fields;
• Identify areas for consideration in the research phase to accelerate or facilitate translation;
• Support new collaborations between UK synthetic biology researchers and bioprocessing technologists